Loading insider details...
Beta
Latest Form 4 (Jul 29, 2026): Grant/Award of 25,000 ACHV shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 29, 2026 | ACHIEVE LIFE SCIENCES, INC. (ACHV) | Grant/Award | 25,000 | n/a |
| Jun 17, 2026 | Tarsus Pharmaceuticals, Inc. (TARS) | Exercise/Conversion | 27,881 | n/a |
| Jun 2, 2026 | ACHIEVE LIFE SCIENCES, INC. (ACHV) | Grant/Award | 47,250 | n/a |
| Mar 19, 2026 | Tarsus Pharmaceuticals, Inc. (TARS) | Sale | 2,111 | $146.5K |
| Mar 17, 2026 | Tarsus Pharmaceuticals, Inc. (TARS) | Exercise/Conversion | 13,042 | n/a |
| Mar 9, 2026 | Tarsus Pharmaceuticals, Inc. (TARS) | Grant/Award | 30,724 | n/a |
| Jun 18, 2025 | Tarsus Pharmaceuticals, Inc. (TARS) | Exercise/Conversion | 27,881 | n/a |
| Mar 21, 2025 | Tarsus Pharmaceuticals, Inc. (TARS) | Sale | 1,284 | $59.4K |
| Mar 19, 2025 | Tarsus Pharmaceuticals, Inc. (TARS) | Exercise/Conversion | 8,019 | n/a |
| Mar 7, 2025 | Tarsus Pharmaceuticals, Inc. (TARS) | Grant/Award | 30,628 | n/a |